Page last updated: 2024-08-24

1,2-distearoyllecithin and Alzheimer Disease

1,2-distearoyllecithin has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antimisiaris, SG; Canovi, M; Clemente, C; Duyckaerts, C; Flores, O; Gobbi, M; Lazar, AN; Markoutsa, E; Masserini, M; Pampalakis, G; Re, F; Salmona, M; Sesana, S1

Other Studies

1 other study(ies) available for 1,2-distearoyllecithin and Alzheimer Disease

ArticleYear
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
    Biomaterials, 2011, Volume: 32, Issue:23

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Antibodies, Monoclonal; Antibody Affinity; Biotin; Brain; Humans; Liposomes; Mice; Mice, Inbred BALB C; Particle Size; Peptide Fragments; Phosphatidylcholines; Phosphatidylethanolamines; Plaque, Amyloid; Polyethylene Glycols; Staining and Labeling; Static Electricity; Surface Plasmon Resonance; Ultracentrifugation

2011